Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B

1. Harnessing the immune system: Insights into cancer vaccines

Sushree Subhadra Acharya, Subhasmita Bhal, Biswajit Das, and

Chanakya Nath Kundu

2. Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy

Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, Soyal Sayyed, Amulya Jindal, Pankaj Kumar, Abhijeet Chinchane, Atreyee Bhattacharyya, Roshani Jaiswal,

Sagar Kulkarni, Shubham Gajdhane, Jitender Madan, and Abhay Asthana

3. Nanoparticles for mRNA-based cancer immunotherapy

Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, and Neeraj Mishra

4. B-cell editing: An emerging alternative of precision oncotherapy

Pritha Roy Choudhury, Mohona Chakravarti, Saptak Banerjee,

Rathindranath Baral, and Anamika Bose

5. Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy

Krishnendu Adhikary, Abhik Paul, Ayush Madan, Anas Islam, Sumel Ashique,
and Mohhammad Ramzan

6. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development

Anas Islam, Vijay Singh, Pooja S. Murkute, Sumel Ashique,

Shriyansh Srivastava, Mohammad Yousuf Ansari, and Sabina Yasmin

7. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy

Monika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, Vijayaraj Surendran, Sumel Ashique, Anas Islam, Naheed Mojgani, and Afzal Hussain